EMA — authorised 26 June 2023
- Marketing authorisation holder: Bristol-Myers Squibb Pharma EEIG
- Status: approved
🇪🇺 Camzyos in European Union
EMA authorised Camzyos on 26 June 2023
Marketing authorisation
Camzyos in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Camzyos approved in European Union?
Yes. EMA authorised it on 26 June 2023.
Who is the marketing authorisation holder for Camzyos in European Union?
Bristol-Myers Squibb Pharma EEIG holds the EU marketing authorisation.